Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Classificação em ações #42724
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$264.00
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
CN
Negociar Biostar Pharmaceuticals, Inc. (BSPM)

Categoria

Preço BSPM com a capitalização de mercado de B
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
BSPM
$0.0001
Capitalização de mercado de Biostar Pharmaceuticals, Inc.(BSPM)
Valor de mercado: $264.00
Em August 2026, Biostar Pharmaceuticals, Inc. tem uma capitalização de mercado de $264.00. Isso faz com que Biostar Pharmaceuticals, Inc. seja a 42724th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Biostar Pharmaceuticals, Inc. de 2008 a 2026
BSPM comparado com o topo de 5 mais populares stocks
Preço para BSPM Ativo B Capitalização de mercado de B Resultados
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$2,055,299 $264.00
$5.426T +2,055,298,683,037.50%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,680,645 $264.00
$4.437T +1,680,645,217,339.39%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,571,025 $264.00
$4.148T +1,571,024,750,840.53%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,387,818 $264.00
$3.664T +1,387,818,418,650.00%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,094,413 $264.00
$2.889T +1,094,412,685,127.27%